"Associate Professor Kevin Pfleger is a National Health and Medical Research Council (NHMRC) RD Wright Biomedical Research Fellow (Level 2) and Head of Molecular Endocrinology and Pharmacology at the Harry Perkins Institute of Medical Research (formerly Western Australian Institute for Medical Research, WAIMR) and The University of Western Australia. Kevin was Chief Scientific Officer of Dimerix Bioscience from 2008 until Dimerix became a public company in June 2014. He was awarded his MA and PhD from Cambridge and Edinburgh Universities respectively. A former National Health and Medical Research Council (NHMRC) Peter Doherty Research Fellow and Australian Research Council (ARC) Future Fellow, Kevin’s recent awards include: Western Australian Young Scientist of the Year 2009, NHMRC 10 of the Best Research Projects 2010, Australian Museum Eureka Prize for Emerging Leader in Science 2011, The Endocrine Society Early Investigators Award 2012, Western Australia Young Tall Poppy Science Award 2012, Endocrine Society of Australia Mid-Career Research Award 2014, NHMRC Research Excellence Award 2014 for the highest ranked fellowship in his category, and the Vice-Chancellor of The University of Western Australia’s Mid-Career Research Award 2015. Kevin is one of the world’s foremost authorities on the use of bioluminescence resonance energy transfer (BRET) technologies to study G protein-coupled receptors. He has published the seminal review and protocol for BRET in Nature Methods and Nature Protocols respectively, and is co-inventor of the HIT technology assigned to Dimerix from The University of Western Australia."

Pharmacology